Form 483

Eduardo E. Rodriguez-Araya, MD Form 483, 2026-05-01

FDA issued a Form 483 to Eduardo E. Rodriguez-Araya, MD on 2026-05-01 with 2 public-safe observations.

483· Form 483 issuedHuman Drugs2 observations

Eduardo E. Rodriguez-Araya, MD · New Orleans, United States · Issued May 1, 2026

Overview

  • 2 public-safe observations are available for this inspection.
  • 2 structured CFR citations are represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

1 May 2026
21 CFR 312.60

FD-1572, protocol compliance

Cited by Laura L Staples, David L Chon

1 May 2026
21 CFR 50.27(a)

Copy of consent form not provided

Cited by Laura L Staples, David L Chon

Inspected site

EEEduardo E. Rodriguez-Araya, MDNew Orleans, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 312.60Cited across public-safe Form 483 observations1x
21 CFR 50.27(a)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 2 observations

The full inspection record, as Atlas holds it, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere